Gene · 369
NIH grants1,471
NIH grants whose papers are about the gene, through NIH's grant-paper links.
501 to 520 of 1,471
Download this page as JSON| Grant | Title | ARAF papers | Newest fiscal year |
|---|---|---|---|
| R35CA197734 | Targeted Therapy for Leukemia | 3 | 2021 |
| R50CA221675 | Functional Proteomics by Reverse Phase Protein Array in Cancer | 3 | 2021 |
| R56AG066712 | A Cytochrome P450 Therapeutic Space for Tauopathies | 3 | 2021 |
| U54CA224068 | An integrated translational approach to overcome drug resistance | 3 | 2021 |
| F31CA265066 | Investigating the biochemical and oncogenic properties of the Ras GTPase RIT1 | 2 | 2021 |
| F32CA232529 | Defining the contributions of WT RAS in RAS-mutant lung cancer | 2 | 2021 |
| K08CA218420 | Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer | 2 | 2021 |
| R01AI083636 | Phosphoproteomic Analysis of Feedback Networks in T cell signaling | 2 | 2021 |
| R01CA125970 | Molecular Predictive Testing in Ocular Melanoma | 2 | 2021 |
| R01HL102368 | Role of RhoA in the Molecular Pathogenesis of Heart Disease. | 2 | 2021 |
| R50CA221830 | Structural biology and drug discovery targeting oncogenic EGFR and BRAF kinases | 2 | 2021 |
| T32GM007280 | Mount Sinai Medical Scientist Training Program | 2 | 2021 |
| T32GM007814 | Predoctoral Training Program in Human Genetics | 2 | 2021 |
| T32GM064337 | Research Training in Chemistry and Chemical Biology | 2 | 2021 |
| U01CA214125 | MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS | 2 | 2021 |
| U01CA224146 | Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens | 2 | 2021 |
| ZIABC011437 | Combinatorial genetic analysis using validated siRNA libraries | 2 | 2021 |
| F30AA026497 | The Role and Mechanisms of Clic4 in Modifying Ethanol-Related Behaviors | 1 | 2021 |
| F30CA232454 | Genetic and Pharmacological Manipulation of KSR in KRAS-driven Cancer | 1 | 2021 |
| F32CA239333 | Systematic Targeting of Oncogene Interacting Proteins to Reveal New Therapeutic Strategies | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/grants?page=26